Location History:
- North Carlton, AU (1996 - 2008)
- Victoria, AU (2008 - 2011)
- Carlton North, AU (2011 - 2012)
- St. Lucia, AU (2014 - 2018)
- St Lucia, AU (2020)
Company Filing History:
Years Active: 1996-2020
Title: **Perry Francis Bartlett: A Pioneering Inventor in Neural Stem Cell Research**
Introduction
Perry Francis Bartlett, an esteemed inventor based in North Carlton, Australia, has made significant contributions to the fields of neuroscience and medical treatments. With 13 patents to his name, Bartlett's work is characterized by innovative approaches to understanding and treating various diseases through the manipulation of neural stem cells and related mechanisms.
Latest Patents
Among his most recent patents is the invention titled "Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereof." This patent discusses a novel approach to treating diseases exacerbated by signaling via the erythropoietin-producing hepatoma receptor kinases EphA4, providing potential therapeutic agents for these conditions.
Another notable patent is centered around a "Latent neural stem cell population," which pertains to a unique population of neural stem cells capable of activation through membrane depolarization. This patent not only details the isolation and culture of these cells but also explores their various uses in neurological research and potential therapies.
Career Highlights
Perry Bartlett has worked at prominent institutions such as The University of Queensland and Amrad Corporation Limited, where he applied his knowledge and expertise to various research initiatives. His work has significantly advanced understanding in his field, contributing to the development of innovative therapeutic solutions.
Collaborations
Throughout his career, Bartlett has collaborated with esteemed colleagues including Andrew W Boyd and Mark Murphy. These partnerships have fostered a collaborative environment, leading to breakthroughs in research and the development of impactful inventions.
Conclusion
Perry Francis Bartlett continues to be a driving force in the domain of neural stem cell research, demonstrating his commitment to innovation through his patents and collaborative efforts. His contributions reflect a deep understanding of the complexities of neural biology and present promising avenues for future medical treatments.